Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AEJ Pharma Consulting AB
AB
Active
Org 5594763780
Landsholmagatan 15
Business and other management consultancy activities · NACE 7020
Est. 2024
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 1,8M
EBITDA margin
45.5%
Equity ratio
42.0%
Financial strength
Net profit 2025
SEK 472K
0 employees
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2025
Key figures
Annual report 2025
Revenue
SEK 1,8M
—
EBITDA
SEK 800K
—
Net profit
SEK 472K
—
Total assets
SEK 1,2M
—
Equity
SEK 497K
—
Employees
0
—
Company information
Legal name
AEJ Pharma Consulting AB
Org number
5594763780
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
18 mars 2024
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget skall bedriva konsultverksamhet inom försäljning och marknadsföring företrädesvis inom life science samt därmed förenlig verksamhet.
Contact
Address
Landsholmagatan 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Lomma
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2025
Income statement
SEK thousands
Item
2025
Revenue
1 760
Staff expenses
—
EBITDA
800
Depreciation & amort.
−0
EBIT
800
Net financials
−5
Profit before tax
595
Tax
−123
Net profit
472
Balance sheet
SEK thousands
Item
2025
Total assets
1 184
Equity
497
Long-term debt
0
Short-term debt
487
Total debt
487
Financial ratios
5-year trend
EBITDA margin
45.5%
This company
15.8%
Market median
+188% vs market
2025
2025
Equity ratio
42.0%
This company
38.2%
Market median
+10% vs market
2025
2025
Return on equity
95.0%
This company
18.4%
Market median
+416% vs market
2025
2025
Net profit margin
26.8%
This company
8.1%
Market median
+231% vs market
2025
2025
Asset turnover
1.49×
This company
1.12×
Market median
+33% vs market
2025
2025
Debt / equity
1.38×
This company
0.62×
Market median
-123% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AE
Anna Ebba Maria Andersson
Deputy Board Member
2024
MA
Maria Agneta Andersson
Board of Directors
2024
Former (4)
CP
Carl Philip Anders Franzén
Deputy Board Member
2024 – 2024
SM
Stina Maria Selldén
Deputy Board Member
2024 – 2024
EA
Erik Alexander Stötsberg
Deputy Board Member
2024 – 2024
MJ
Mikaela Jenni Berglund
Board of Directors
2024 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of AEJ Pharma Consulting AB also hold positions in
0
other companies.
Person
Role here
Other companies
Carl Philip Anders Franzén
Deputy Board Member
0 companies
Anna Ebba Maria Andersson
Deputy Board Member
0 companies
Maria Agneta Andersson
Board of Directors
0 companies
Stina Maria Selldén
Deputy Board Member
0 companies
Erik Alexander Stötsberg
Deputy Board Member
0 companies
Mikaela Jenni Berglund
Board of Directors
0 companies